INFECTIOUS DECAY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PLASMA

被引:28
作者
MOUDGIL, T [1 ]
DAAR, ES [1 ]
机构
[1] UNIV CALIF LOS ANGELES,CEDARS SINAI MED CTR,SCH MED,DEPT MED,DIV INFECT DIS B225,LOS ANGELES,CA 90048
关键词
D O I
10.1093/infdis/167.1.210
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
AIDS is caused by the human immunodeficiency virus type 1 (HIV-1). Recent methods have been developed to estimate infectious titer in various bodily fluids, including blood. However, lack of information about HIV-1 stability in blood has restricted the use of these techniques to fresh samples in immediately accessible virology laboratories. In studies of infectious virus decay, it was found that at room temperature, complete decay of infectious HIV-1 in plasma can require > 7 days. Furthermore, the stability of HIV-1 was enhanced by storage at 4-degrees-C, suggesting that fresh plasma could be sent on ice to core laboratories for viral quantitation. These studies also emphasize the need for thorough decontamination of all potentially infectious material.
引用
收藏
页码:210 / 212
页数:3
相关论文
共 10 条
  • [1] BARRESINOUSSI F, 1983, SCIENCE, V220, P761
  • [2] HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION
    CLARK, SJ
    SAAG, MS
    DECKER, WD
    CAMPBELLHILL, S
    ROBERSON, JL
    VELDKAMP, PJ
    KAPPES, JC
    HAHN, BH
    SHAW, GM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 954 - 960
  • [3] PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    COOMBS, RW
    COLLIER, AC
    ALLAIN, JP
    NIKORA, B
    LEUTHER, M
    GJERSET, GF
    COREY, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) : 1626 - 1631
  • [4] HIGH-CONCENTRATIONS OF RECOMBINANT SOLUBLE CD4 ARE REQUIRED TO NEUTRALIZE PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
    DAAR, ES
    LI, XL
    MOUDGIL, T
    HO, DD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6574 - 6578
  • [5] TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    DAAR, ES
    MOUDGIL, T
    MEYER, RD
    HO, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 961 - 964
  • [6] QUANTITATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN THE BLOOD OF INFECTED PERSONS
    HO, DD
    MOUDGIL, T
    ALAM, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) : 1621 - 1625
  • [7] STABILITY AND INACTIVATION OF HTLV-III LAV UNDER CLINICAL AND LABORATORY ENVIRONMENTS
    RESNICK, L
    VEREN, K
    SALAHUDDIN, SZ
    TONDREAU, S
    MARKHAM, PD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (14): : 1887 - 1891
  • [8] HIGH-LEVEL VIREMIA IN ADULTS AND CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - RELATION TO DISEASE STAGE AND CD4+ LYMPHOCYTE LEVELS
    SAAG, MS
    CRAIN, MJ
    DECKER, WD
    CAMPBELLHILL, S
    ROBINSON, S
    BROWN, WE
    LEUTHER, M
    WHITLEY, RJ
    HAHN, BH
    SHAW, GM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (01) : 72 - 80
  • [9] 1987, MMWR, V36, pS1
  • [10] 1991, MMWR, V40, P21